Transcutaneous Electrical Stimulation Aids Gastroesophageal Reflux Disease
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 4, 2025 -- A transcutaneous electrical stimulation system (TESS) is effective in reducing both symptoms and esophageal acid exposure time in patients with gastroesophageal reflux disease (GERD), according to a study published online Jan. 23 in Neurogastroenterology & Motility.
Ram Dickman, M.D., from the Rabin Medical Center in Petah Tikva, Israel, and colleagues assessed the effect of TESS on GERD symptoms and acid exposure time. The analysis included 26 patients who had increased acid exposure time (percent total time pH <4 above 6 percent) and who were treated for up to three weeks with TESS.
The researchers found the mean numbers of daily heartburn and regurgitation episodes were 2.55 and 1.40, respectively, which dropped to 0.77 and 0.36, respectively, following TESS. At baseline, mean acid exposure time and DeMeester score were 12.4 and 32.1, respectively, which dropped to 6.0 and 16.2, respectively, following TESS.
"In summary, TESS appears to be safe and effective in reducing esophageal acid exposure and improving heartburn and regurgitation in GERD patients," the authors write. "A larger prospective, sham-controlled study is currently designed to verify these early results."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications
THURSDAY, July 17, 2025 -- For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal...
Increase in Chronic Digestive Disorders Seen During Pandemic
WEDNESDAY, July 9, 2025 -- There was an increase in disorders of gut-brain interaction (DGBI) during the COVID-19 pandemic for those living in the United States, according to a...
Capsule Sponge + Biomarkers Can Stratify Risk in Barrett Esophagus
MONDAY, June 30, 2025 -- In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying those at highest risk...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.